60 new jobs for Mullingar
Sixty new jobs are on their way to Mullingar following this morning’s announcement that Antylia Scientific is to establish a Masterflex Bioprocessing facility in the National Science Park.
The project is supported by the Irish Government through IDA Ireland.
Minister for Trade Promotion, Digital and Company Regulation Robert Troy TD said: “I am delighted that Antylia has chosen to establish its new facility in Mullingar, creating some 60 new highly skilled jobs.
“It is a significant announcement for Mullingar and a strong endorsement of the midlands as an excellent location for businesses to establish and thrive.
“Our highly skilled workforce is just one reason Ireland is recognised as a global hub for leading biopharmaceutical companies like Antylia Scientific."
“Our mission in government is to get people back to work and rebuild the economy and a priority focus for me in the Department of Enterprise is to promote balanced regional development across the country.
“I wish Antylia Scientific every success with its new facility in Mullingar.”
The new Masterflex Bioprocessing facility will be used to design and manufacture the Masterflex peristaltic technologies that are used in pharmaceutical and bioprocessing for the development and production of vaccines and therapeutics.
The facility will also include a large warehouse space to store components and the finished products.
Brian Barnett, president of Masterflex Bioprocessing, said: “We are grateful to the Irish Government through IDA Ireland for this opportunity, and we are thrilled to open our first facility in Ireland to produce and house Masterflex peristaltic technologies and associated fluid path products.
“These products are in great demand globally. The addition of this site to our Masterflex Bioprocessing family of global sites providing products and services will help the overall Biopharma industry.
“It is a win-win situation that will positively benefit our customers, our Masterflex brand, and the Mullingar workforce and economy.”
The jobs being created at the new Masterflex Bioprocessing facility in Mullingar are in the areas of process and medical device engineering, manufacturing, and logistics and supply chain.
The CEO of IDA Ireland, Martin Shanahan, said: “Today’s announcement by Antylia Scientific is a positive one for the midlands and is a strong endorsement in the region’s talented and highly skilled Biopharma and MedTech workforce.
“Antylia Scientific’s significant investment in its facility at the National Science Park demonstrates its commitment to the region. I wish Antylia every success with this investment.”
To explore opportunities to join the Antylia Scientific team in Mullingar, visit Antylia Scientific on LinkedIn or to learn more about Antylia Scientific and Masterflex please visit www.antylia.com and www.masterflex.com.
ABOUT ANTYLIA SCIENTIFIC
Antylia Scientific is a global leader in peristaltic and single use bioprocessing solutions as well as a diverse portfolio of life sciences and diagnostic products for the pharma, biopharma, healthcare and environmental markets. Antylia Scientific consists of two operating divisions, Bioprocessing and Life Sciences.
Its bioprocessing portfolio includes industry leading Masterflex I/P, L/S, B/T, and Ismatec Reglo range of peristaltic pumps, MasterflexLive connected products, pump and transfer tubing, flow meters and associated fluid path products.
Its life sciences portfolio includes brands such as the environmental sampling and testing innovator, Environmental Express; real-time monitoring and cold storage expertise at Traceable; standards and external diagnostic control specialists, SPEX and ZeptoMetrix; and the lab essentials and consumables Cole-Parmer brand.